Perflutren protein type a microsphere (Intravenous)

Medically reviewed by Drugs.com. Last updated on Mar 27, 2022.

Commonly used brand name(s)

In the U.S.

• Optison

Available Dosage Forms:

• Suspension

Therapeutic Class: Diagnostic Agent, Cardiac Function

Uses for perflutren protein type a microsphere

Perflutren protein type A microsphere injection is used during an echocardiogram to help diagnose or find problems in the heart.

Perflutren protein type A microsphere is an ultrasound contrast agent. Ultrasound contrast agents are used to help provide a clear picture during ultrasound. Ultrasound is a special kind of diagnostic procedure. It uses high-frequency sound waves to create images or “pictures” of certain areas inside the body. The sound waves produced by the ultrasound equipment can be reflected (bounced off) by different parts of the body, such as, the heart. As the sound waves return they are electronically converted into images on a television screen. Unlike x-rays, ultrasound does not involve ionizing radiation. The albumin microspheres sonicated preparation contains very small gas-filled albumin microspheres that reflect the sound waves and help create a better picture.

Perflutren protein type a microsphere is to be given only by or under the direct supervision of a doctor with specialized training in ultrasound procedures.

Before using perflutren protein type a microsphere

In deciding to use a diagnostic test, any risks of the test must be weighed against the good it will do. This is a decision you and your doctor will make. Also, other things may affect test results. For this test, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to perflutren protein type a microsphere or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of perflutren protein type A microsphere injection in the pediatric population. Safety and efficacy have not been established. .

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of perflutren protein type A microsphere injection in the elderly. However, elderly patients are more sensitive to the effects of perflutren protein type a microsphere than younger adults.

Breastfeeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with medicines

Although certain medicines should not be used together at all, in other ca..